Backed by 20 rigorous clinical studies
The combination of the lactotripeptides VPP and IPP has been shown effective in both hypertensive and pre-hypertensive patients in 20 rigorous, placebo-controlled clinical studies conducted in Japan, Europe and the US.
These studies have been reviewed and endorsed by an independent, third party group in a meta-analysis published in the British Journal of Nutrition (2008).
Customers with questions about AmealPeptide® are encouraged to talk to their doctor.